Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-12-127906
Filing Date
2012-03-23
Accepted
2012-03-22 19:50:07
Documents
8

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT d319421dposam.htm POS AM 1060485
2 CONSENT OF OUM & CO., LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d319421dex231.htm EX-23.1 1877
  Complete submission text file 0001193125-12-127906.txt   2900965

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT ttnp-20111231.xml EX-101.INS 347401
4 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20111231.xsd EX-101.SCH 15080
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20111231_cal.xml EX-101.CAL 32691
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20111231_def.xml EX-101.DEF 12229
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20111231_lab.xml EX-101.LAB 125049
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20111231_pre.xml EX-101.PRE 84394
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-166351 | Film No.: 12710260
SIC: 2836 Biological Products, (No Diagnostic Substances)